Informazione:
Errore:
ID
21055
Descrizione
Dose Dense Abraxane in Adjuvant Chemotherapy for Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00308178
collegamento
https://clinicaltrials.gov/show/NCT00308178
Keywords
versioni (1)
- 06/04/17 06/04/17 -
Caricato su
6 aprile 2017
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY 4.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Eligibility Breast Cancer NCT00308178
Eligibility Breast Cancer NCT00308178
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00308178
- StudyEvent: Eligibility
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
breast cancer
Item
histologically or cytologically confirmed breast cancer, with clinical stage i, ii, or iii disease
boolean
C0678222 (UMLS CUI [1,1])
C0010819 (UMLS CUI [1,2])
C0019638 (UMLS CUI [1,3])
C0178759 (UMLS CUI [1,4])
C0010819 (UMLS CUI [1,2])
C0019638 (UMLS CUI [1,3])
C0178759 (UMLS CUI [1,4])
adjuvant or neoadjuvant chemotherapy
Item
must register at the beginning of adjuvant or neoadjuvant chemotherapy
boolean
C0085533 (UMLS CUI [1])
C4272610 (UMLS CUI [2])
C4272610 (UMLS CUI [2])
age
Item
18 years of age or older
boolean
C0001779 (UMLS CUI [1])
ecog
Item
ecog performance status of 0 or 1
boolean
C1520224 (UMLS CUI [1])
normal organ and marrow function
Item
normal organ and marrow function
boolean
C1254358 (UMLS CUI [1])
previous chemotherapy or radiotherapy
Item
previous cytotoxic chemotherapy or therapeutic radiation therapy for any reason
boolean
C0392920 (UMLS CUI [1,1])
C1522449 (UMLS CUI [1,2])
C1522449 (UMLS CUI [1,2])
pregnancy or breast feeding
Item
pregnant or nursing
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
investigational agents
Item
receiving any other investigational agents
boolean
C1875319 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,2])
stage iv breast cancer
Item
patients with stage iv breast cancer
boolean
C0278488 (UMLS CUI [1])
neuropathy
Item
current grade ii or greater peripheral neuropathy or prior history of grade ii or greater neuropathy
boolean
C0031117 (UMLS CUI [1])
C0442874 (UMLS CUI [2])
C0442874 (UMLS CUI [2])
comorbidity
Item
uncontrolled intercurrent illness, including but not limited to, ongoing or active infection, symptomatic congestive heart failure, uncontrolled hypertension, unstable angina pectoris, cardiac arrythmia, or psychiatric illness/social situations that would limit compliance with study requirements
boolean
C0009488 (UMLS CUI [1])
immune deficiency
Item
immune deficiency when treated with marrow-suppressive therapy or hiv-positive patients receiving anti-retroviral therapy
boolean
C1855771 (UMLS CUI [1])
sickle cell disease
Item
patients with sickle cell disease
boolean
C0037054 (UMLS CUI [1])
hyperviscosity syndrome
Item
known history of hyperviscosity syndrome
boolean
C0221030 (UMLS CUI [1])
lithium
Item
patients on lithium
boolean
C0023870 (UMLS CUI [1])